Literature DB >> 856919

Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B.

G W Pettit, M R Elwell, P B Jahrling.   

Abstract

Staphylococcus aureus enterotoxin B (SEB) administered intravenously may exert its toxicity by damaging capillary endothelium in the large intestine and, thereby, permit absorption of endotoxin into the circulation. To investigate this possibility, we measured an index of the level of plasma endotoxin. This index was the ability of plasma to cause gelation of limulus amebocyte lysate (GLAL), before and after intravenous administration of SEB (800-1,000 microng/kg of body weight) to 13 rabbits. All samples taken before administration of SEB were negative for GLAL, but GLAL activity was detectable in the plasma of 10 of the rabbits 12 hr after SEB was injected. Only rabbits that developed GLAL activity died; the levels of GLAL in plasma were comparable to those detected by other workers after administration of an intravenous, lethal dose of endotoxin to rabbits.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856919     DOI: 10.1093/infdis/135.4.646

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.

Authors:  T Krakauer; B G Stiles
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Staphylococcal enterotoxin A-induced fever is associated with increased circulating levels of cytokines in rabbits.

Authors:  W T Huang; M T Lin; S J Won
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Staphylococcal enterotoxin A acts through nitric oxide synthase mechanisms in human peripheral blood mononuclear cells to stimulate synthesis of pyrogenic cytokines.

Authors:  S J Won; W T Huang; Y S Lai; M T Lin
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B.

Authors:  Martha L Hale; Solomon B Margolin; Teresa Krakauer; Chad J Roy; Bradley G Stiles
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

6.  Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D.

Authors:  J Y Chen; Y Qiao; J L Komisar; W B Baze; I C Hsu; J Tseng
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.

Authors:  J Parsonnet; Z A Gillis; A G Richter; G B Pier
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 8.  The staphylococcal enterotoxin (SE) family: SEB and siblings.

Authors:  Teresa Krakauer; Bradley G Stiles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.